Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sun Genomics, operating primarily under the brand name Floré, is a direct-to-consumer microbiome health company specializing in personalized probiotics. The company utilizes high-resolution whole-genome sequencing to analyze a customer's gut microbiome from a stool sample, identifying specific bacterial strains and their relative abundance. Based on this data, Sun Genomics formulates custom probiotic supplements tailored to the individual's unique gut profile to address issues such as bloating, digestion, and inflammation. Their platform aims to move beyond one-size-fits-all probiotic solutions by providing precision supplements and longitudinal tracking of gut health improvements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Flore.